688266.SH上海证券交易所 · 科创板 STAR
Zelgen 泽璟制药
Chemical Pharmaceuticals 化学制药
¥108.95−¥7.10 · −6.12%
Open 开盘
¥116.66
High 最高
¥116.68
Low 最低
¥108.50
Prev Close 昨收
¥116.05
Volume 成交量
348.1万股
Turnover 成交额
¥3.86亿
Mkt Cap 总市值
¥288亿
P/E 市盈率
52.5×
Recent Activity 近期动态All Filings 全部公告 →
5 broker reports from 4 firms since 30 May 2026, the latest on 10 Aug 2026.
自 30 May 2026 起有 5 份研报，来自 4 家券商，最新一份见于 10 Aug 2026。
8090100110120130140
Volume 成交量
1,535.2万
Sep 25Dec 25Mar 26Jun 26Sep 26
Overview 概览Deep Report 深度报告Financials 财务Valuation 估值Ownership 股东Analysts 券商Estimates 预测News 动态Events 事件Peers 同业
Last Twelve Months 近十二个月
10 reports from 6 brokers · 1 unrated 6 家券商 10 份研报，1 份无评级
Reports Share Market
Buy 买入 7 77.8% 70.7%
Outperform 增持 2 22.2% 28.6%
Neutral 中性 0 0.0% 0.7%
Underperform 减持 0 0.0% 0.0%
Sell 卖出 0 0.0% 0.0%
The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.
Rating Changes 评级变动
No broker has changed its rating on this company in the reports held.
Current Coverage 当前覆盖
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 国信证券 | 陈曦炳,彭思宇,肖婧舒 | Outperform 增持 | 10 Aug 2026 | 2 | — |
| 中邮证券 | 盛丽华,陈灿 | Buy 买入 | 7 Aug 2026 | 1 | — |
| 东吴证券 | 朱国广,苏丰 | Buy 买入 | 5 Aug 2026 | 3 | — |
| 开源证券 | 余汝意,聂媛媛 | Buy 买入 | 5 Aug 2026 | 2 | — |
| 西南证券 | 杜向阳,汤泰萌 | Unrated | 31 Mar 2026 | 1 | — |
| 华安证券 | 谭国超,任婉莹 | Buy 买入 | 2 Nov 2025 | 1 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 1 of 10 reports. 每行为该券商近十二个月的最新研报；10 份中 1 份给出目标价。
Coverage by Quarter 覆盖变化
2 23Q4
0 24Q1
3 24Q2
4 24Q3
2 24Q4
0 25Q1
3 25Q2
4 25Q3
2 25Q4
2 26Q1
2 26Q2
4 26Q3
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。